Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
AMPK Pathway Emerges as Master Switch for Mitochondrial RejuvenationLongevity & Aging

AMPK Pathway Emerges as Master Switch for Mitochondrial Rejuvenation

AMPK (AMP-activated protein kinase) is an ancient, evolutionarily conserved energy sensor found in all eukaryotes. When cellular ATP falls, AMPK activates a coordinated program that simultaneously promotes mitochondrial fission to isolate damaged organelles, triggers mitophagy to clear them via lysosomes, and stimulates biogenesis to synthesize fresh mitochondria. Upstream kinases LKB1 and CAMKK2 phosphorylate AMPK at Thr172 to fully activate it. Pharmacological activators—including the diabetes drug metformin and direct ADaM-site agonists like MK-8722—mimic exercise-induced AMPK activation. Dysregulation of these AMPK-governed processes is implicated in neurodegeneration, cancer, and aging, making AMPK a compelling therapeutic target for longevity-related metabolic diseases.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.